NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 12 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,161,719 | -49.9% | 1,250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $2,320,312 | +121.5% | 2,500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $1,047,656 | -3.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,080,000 | +4.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,038,000 | -2.6% | 1,250,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,066,000 | -28.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q4 2021 | $1,481,000 | -19.7% | 1,250,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,845,000 | +4.1% | 1,250,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,772,000 | -5.7% | 1,250,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,880,000 | -53.9% | 1,250,000 | -50.0% | 0.00% | – |
| Q4 2020 | $4,078,000 | +30.5% | 2,500,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,125,000 | +16.8% | 2,500,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,675,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
| Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
| Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
| LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |